We use cookies to provide you with the best of services and customized features. By continuing to browse this website, you give your informed consent to our Cookie Policy.
The hemolytic potential of all intravenously administered pharmaceuticals must be evaluated.
Hemolysis (destruction of red blood cells) in vivo can lead to anemia, jaundice and other
pathological conditions.
